• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围手术期药物假期管理应用程序的开发。

Development of an application for management of drug holidays in perioperative periods.

作者信息

Kimura Sakiko, Emoto Akiko, Yoshimura Mariko, Arimizu Kota, Kamura Tomoko, Sogawa Rintaro, Mizuta Kikumi, Tagomori Yasuhiro, Natsuaki Masahiro, Kajiwara Masataka, Tsuruoka Nanae, Yakushiji Yusuke, Tanigawa Yoshinori, Takamatsu Chihiro, Danjo Atsushi, Kamohara Keiji, Hirakawa Naomi, Sakaguchi Yoshiro, Noguchi Mitsuru, Noshiro Hirokazu, Kawaguchi Atsushi, Sueoka Eisaburo, Narisawa Yutaka, Kimura Shinya

机构信息

Safety Management Section, Saga University Hospital.

Dep. of Pharmacy, Saga University Hospital.

出版信息

Medicine (Baltimore). 2020 May;99(19):e20142. doi: 10.1097/MD.0000000000020142.

DOI:10.1097/MD.0000000000020142
PMID:32384497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7220215/
Abstract

Before surgery and other invasive treatments, decisions must be made on whether to discontinue drugs and provide appropriate drug holidays especially for antithrombotic drugs, and this is made difficult by the large number of available drugs and associated guidelines. We have therefore developed an online application for perioperative drug discontinuation and resumption management, named Saga Application for Management of Drug Holidays in PeriOperative Periods (SAMPOP).Multidisciplinary medical staff at Saga University Hospital (SUH) worked together to build an evidence-based Perioperative Drug Discontinuation Management Database (PDDMD) and developed the user-friendly SAMPOP online application via preliminary verification at SUH. From September 2018 to February 2020, 420 medical staff at SUH, including physicians, nurses, and pharmacists, installed and tested SAMPOP.Rate per surgical procedure for forgetting to discontinue antithrombotic drugs preoperatively decreased from 0.18% to 0.09% as of August 2019, 12 months after the introduction of SAMPOP (P = .1359). In addition, six months later, it decreased further to 0.03% as of February 2020 (P = .0436). Forgetting to resume antithrombotic drugs postoperatively decreased from 0.20% to 0.02% as of August 2019, 12 months after the introduction of SAMPOP (P = .0008). There was no case of forgetting to resume the medication in the last 6 months.SAMPOP may be useful for management of drug holidays in the clinic and warrants further evaluation of its safety and efficacy.

摘要

在手术和其他侵入性治疗之前,必须决定是否停用药物并提供适当的药物假期,尤其是抗血栓药物,而大量可用药物和相关指南使得这一决策变得困难。因此,我们开发了一个用于围手术期药物停用和恢复管理的在线应用程序,名为围手术期药物假期管理佐贺应用程序(SAMPOP)。佐贺大学医院(SUH)的多学科医务人员共同建立了一个基于证据的围手术期药物停用管理数据库(PDDMD),并通过在SUH的初步验证开发了用户友好的SAMPOP在线应用程序。从2018年9月到2020年2月,SUH的420名医务人员,包括医生、护士和药剂师,安装并测试了SAMPOP。截至2019年8月,即引入SAMPOP后的12个月,术前忘记停用抗血栓药物的每个手术程序发生率从0.18%降至0.09%(P = 0.1359)。此外,6个月后,截至2020年2月,该发生率进一步降至0.03%(P = 0.0436)。术后忘记恢复使用抗血栓药物的情况截至2019年8月,即引入SAMPOP后的12个月,从0.20%降至0.02%(P = 0.0008)。在过去6个月中没有忘记恢复用药的情况。SAMPOP可能对临床药物假期管理有用,值得进一步评估其安全性和有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03f/7220215/4acde70e151f/medi-99-e20142-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03f/7220215/79f7c9887aef/medi-99-e20142-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03f/7220215/4acde70e151f/medi-99-e20142-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03f/7220215/79f7c9887aef/medi-99-e20142-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03f/7220215/4acde70e151f/medi-99-e20142-g004.jpg

相似文献

1
Development of an application for management of drug holidays in perioperative periods.围手术期药物假期管理应用程序的开发。
Medicine (Baltimore). 2020 May;99(19):e20142. doi: 10.1097/MD.0000000000020142.
2
Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.介入技术出血风险评估:抗凝和抗血栓治疗的实践模式和围手术期管理的最佳证据综合。
Pain Physician. 2013 Apr;16(2 Suppl):SE261-318.
3
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2.多学科方法在冠状动脉支架置入术后手术患者围手术期抗栓治疗中的应用:支架术后手术 2 。
JACC Cardiovasc Interv. 2018 Mar 12;11(5):417-434. doi: 10.1016/j.jcin.2017.10.051.
4
Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients Undergoing Interventional Techniques: American Society of Interventional Pain Physicians (ASIPP) Guidelines.介入技术治疗患者中抗血栓和抗凝药物的合理、安全、有效应用:美国介入疼痛医师学会(ASIPP)指南。
Pain Physician. 2019 Jan;22(1S):S75-S128.
5
Evidence based development of bedside clinical drug rules for surgical patients.基于证据的外科患者床边临床用药规则的制定。
Int J Clin Pharm. 2014 Jun;36(3):581-8. doi: 10.1007/s11096-014-9941-x. Epub 2014 Apr 20.
6
Implementation of hyperlinks to medication management policies and guidelines in the electronic health record.实现电子健康记录中药物管理政策和指南的超链接。
Am J Health Syst Pharm. 2019 Sep 1;76(Supplement_3):S69-S73. doi: 10.1093/ajhp/zxz122.
7
Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.抗栓治疗指南:围手术期抗栓治疗管理及桥接抗凝的应用
Int Angiol. 2008 Aug;27(4):333-43.
8
Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.微创和传统心胸外科手术中血液管理的药物、器械、技术与方法:国际微创心胸外科协会(ISMICS)2011年共识声明
Innovations (Phila). 2012 Jul-Aug;7(4):229-41. doi: 10.1097/IMI.0b013e3182747699.
9
Safety and Management of Antithrombotic Therapy with Intra-Arterial Catheter Procedures.动脉内导管操作抗栓治疗的安全性与管理
Intern Med. 2015;54(17):2115-20. doi: 10.2169/internalmedicine.54.4071. Epub 2015 Sep 1.
10
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.抗栓治疗的围手术期管理:抗栓治疗与血栓预防,第 9 版:美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e326S-e350S. doi: 10.1378/chest.11-2298.

引用本文的文献

1
Risk Factors for Non-Adherence to Pharmacist or Non-Pharmacist Explanations on Preoperative Medication Discontinuation: A Retrospective Japanese Study.术前停药时不遵循药剂师或非药剂师解释的风险因素:一项日本回顾性研究。
Patient Prefer Adherence. 2024 Jan 31;18:255-266. doi: 10.2147/PPA.S445474. eCollection 2024.

本文引用的文献

1
Local haemostatic measures after tooth removal in patients on antithrombotic therapy: a systematic review.抗血栓治疗患者拔牙后局部止血措施:系统评价。
Clin Oral Investig. 2019 Apr;23(4):1695-1708. doi: 10.1007/s00784-018-2576-x. Epub 2018 Aug 28.
2
Corrigendum to: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.《2017年欧洲心脏病学会与欧洲心胸外科协会合作制定的冠状动脉疾病双联抗血小板治疗重点更新》勘误
Eur Heart J. 2018 Jun 7;39(22):2089. doi: 10.1093/eurheartj/ehx638.
3
Dental management in patients with antiplatelet therapy: A systematic review.
抗血小板治疗患者的牙科管理:一项系统评价。
J Clin Exp Dent. 2017 Aug 1;9(8):e1044-e1050. doi: 10.4317/jced.54079. eCollection 2017 Aug.
4
Association of Ibrutinib Treatment With Bleeding Complications in Cutaneous Surgery.依鲁替尼治疗与皮肤外科手术出血并发症的关联
JAMA Dermatol. 2017 Oct 1;153(10):1069-1070. doi: 10.1001/jamadermatol.2017.1877.
5
2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force.2017 年美国心脏病学会专家共识决策路径:非瓣膜性心房颤动患者抗凝治疗围术期管理:美国心脏病学会临床专家共识文件工作组的报告。
J Am Coll Cardiol. 2017 Feb 21;69(7):871-898. doi: 10.1016/j.jacc.2016.11.024. Epub 2017 Jan 9.
6
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.更新的欧洲心脏节律协会实用指南:非维生素 K 拮抗剂抗凝剂在非瓣膜性心房颤动患者中的应用。
Europace. 2015 Oct;17(10):1467-507. doi: 10.1093/europace/euv309. Epub 2015 Aug 31.
7
Lactic acidosis.乳酸性酸中毒
N Engl J Med. 2014 Dec 11;371(24):2309-19. doi: 10.1056/NEJMra1309483.
8
Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions.伊布替尼治疗影响胶原和血管性血友病因子依赖的血小板功能。
Blood. 2014 Dec 18;124(26):3991-5. doi: 10.1182/blood-2014-06-583294. Epub 2014 Oct 10.
9
Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation.伊布替尼抑制胶原介导的血小板聚集,但不抑制 ADP 介导的血小板聚集。
Leukemia. 2015 Apr;29(4):783-7. doi: 10.1038/leu.2014.247. Epub 2014 Aug 20.
10
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013).心房颤动药物治疗指南(日本循环学会2013年版)
Circ J. 2014;78(8):1997-2021. doi: 10.1253/circj.cj-66-0092. Epub 2014 Jun 26.